OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00507058

Cosmo Advanced Materials & Technology Co Ltd

Commodity ChemicalsVerified

The company's capital structure shows a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry norm. However, the liquidity risk is rated as medium, and the current ratio of 0.89 suggests that the company may struggle to meet short-term obligations with its current assets. The negative net cash position after subtracting total debt raises concerns about short-term liquidity. Profitability metrics are weak, with a return on equity of -0.0011 and a return on assets of -0.0007, both significantly below the industry median for commodity chemicals. The company reported a net loss of 522.85 million KRW, despite a gross profit of 27.18 billion KRW, indicating high operating costs or inefficiencies in cost management. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification. This concentration increases exposure to sector-specific risks and limits the ability to offset losses in one area with gains in another. Looking ahead, the company's revenue is expected to remain under pressure, with no clear growth trajectory evident from the current financial data. The capital expenditure of -45.98 billion KRW suggests a reduction in investment, which may impact long-term growth potential. The free cash flow is negative at -32.00 billion KRW, further constraining the company's ability to reinvest or return value to shareholders. The risk assessment highlights liquidity concerns, with a medium risk rating and a key flag indicating negative net cash after debt. The dilution risk is rated as low, and no significant dilution events are expected in the near term. However, the company's negative net income and weak cash flow metrics suggest a need for close monitoring of capital structure decisions. Recent filings and transcripts do not indicate any major strategic shifts or operational changes. The company's financial performance remains a concern, with analysts providing a mean price target of 62,666.67 KRW and a median of 68,000.00 KRW, suggesting a cautious outlook from the investment community.

30-day price · 005070+600.00 (+1.2%)
Low$50200.00High$66400.00Close$52000.00As of15 May, 00:00 UTC
Profile
CompanyCosmo Advanced Materials & Technology Co Ltd
Ticker005070.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Cosmo Advanced Materials & Technology Co Ltd produces and sells chemical products, primarily in the commodity chemicals segment, generating revenue through the sale of these materials to industrial and manufacturing customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

The company's capital structure shows a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry norm. However, the liquidity risk is rated as medium, and the current ratio of 0.89 suggests that the company may struggle to meet short-term obligations with its current assets. The negative net cash position after subtracting total debt raises concerns about short-term liquidity. Profitability metrics are weak, with a return on equity of -0.0011 and a return on assets of -0.0007, both significantly below the industry median for commodity chemicals. The company reported a net loss of 522.85 million KRW, despite a gross profit of 27.18 billion KRW, indicating high operating costs or inefficiencies in cost management. The company's revenue is concentrated in a single business segment, as disclosed in its financial reporting, with no material geographic diversification. This concentration increases exposure to sector-specific risks and limits the ability to offset losses in one area with gains in another. Looking ahead, the company's revenue is expected to remain under pressure, with no clear growth trajectory evident from the current financial data. The capital expenditure of -45.98 billion KRW suggests a reduction in investment, which may impact long-term growth potential. The free cash flow is negative at -32.00 billion KRW, further constraining the company's ability to reinvest or return value to shareholders. The risk assessment highlights liquidity concerns, with a medium risk rating and a key flag indicating negative net cash after debt. The dilution risk is rated as low, and no significant dilution events are expected in the near term. However, the company's negative net income and weak cash flow metrics suggest a need for close monitoring of capital structure decisions. Recent filings and transcripts do not indicate any major strategic shifts or operational changes. The company's financial performance remains a concern, with analysts providing a mean price target of 62,666.67 KRW and a median of 68,000.00 KRW, suggesting a cautious outlook from the investment community.
Key takeaways
  • The company's debt-to-equity ratio of 0.27 suggests a relatively conservative capital structure, but the current ratio of 0.89 indicates potential liquidity challenges.
  • Return on equity and return on assets are negative, signaling poor profitability and underperformance relative to industry standards.
  • Revenue is concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Free cash flow is negative, and capital expenditures are declining, which may limit long-term growth potential.
  • Analysts have a cautiously optimistic outlook, with a mean price target of 62,666.67 KRW and a median of 68,000.00 KRW.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$456.30B
Gross profit$27.18B
Operating income$2.38B
Net income-$522.9M
R&D
SG&A
D&A
SBC
Operating cash flow$138.23B
CapEx-$45.98B
Free cash flow-$32.00B
Total assets$721.10B
Total liabilities$224.26B
Total equity$496.84B
Cash & equivalents
Long-term debt$133.24B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$456.30B$2.38B-$522.9M-$32.00B
FY-1$569.73B$24.97B$17.65B-$156.48B
FY-2$629.58B$32.27B$27.04B-$60.54B
FY-3$485.61B$32.42B$27.70B$23.39B
FY-4$305.89B$21.74B$18.00B-$10.01B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$721.10B$496.84B
FY-1$784.54B$495.53B
FY-2$672.67B$478.78B
FY-3$451.32B$251.20B
FY-4$348.48B$205.45B
PeriodOCFCapExFCFSBC
FY0$138.23B-$45.98B-$32.00B
FY-1$9.07B-$188.20B-$156.48B
FY-2-$28.88B-$103.54B-$60.54B
FY-3$544.8M-$20.25B$23.39B
FY-4$26.04B-$41.05B-$10.01B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$122.72B$874.0M-$3.57B-$7.58B
FQ-1$117.04B$670.8M-$2.12B-$11.53B
FQ-2$105.25B$134.7M-$2.60B-$9.66B
FQ-3$120.13B$528.8M$2.28B-$2.61B
FQ-4$113.88B$1.04B$1.92B-$8.19B
FQ-5$142.90B$6.25B$1.11B-$19.45B
FQ-6$119.34B$6.52B$7.64B-$12.14B
FQ-7$185.39B$6.92B$4.29B-$47.05B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$810.33B$538.38B$95.00B
FQ-1$721.10B$496.84B
FQ-2$743.60B$494.67B
FQ-3$752.31B$497.24B
FQ-4$749.71B$497.42B
FQ-5$784.54B$495.53B
FQ-6$742.09B$495.27B$160.00
FQ-7$738.62B$487.65B$50.00
PeriodOCFCapExFCFSBC
FQ0-$35.20B-$7.73B-$7.58B
FQ-1$138.23B-$45.98B-$11.53B
FQ-2$91.83B-$32.92B-$9.66B
FQ-3$70.79B-$22.24B-$2.61B
FQ-4$63.93B-$13.73B-$8.19B
FQ-5$9.07B-$188.20B-$19.45B
FQ-6$57.71B-$164.21B-$12.14B
FQ-7$51.60B-$140.98B-$47.05B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$496.84B
Net cash-$133.24B
Current ratio0.9
Debt/Equity0.3
ROA-0.1%
ROE-0.1%
Cash conversion-264.4%
CapEx/Revenue-10.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric005070Activity
Op margin0.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin-0.1%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin6.0%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-10.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity27.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean price target62,666.67 KRW
Median price target68,000.00 KRW
High price target70,000.00 KRW
Low price target50,000.00 KRW
Mean recommendation1.67 (1=strong buy, 5=strong sell)
Strong-buy count1.00
Buy count2.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate311.50 KRW
Last actual EPS-16.00 KRW
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 01:14 UTCJob: 2c2f93d0